GALLAGHER NEIL (President, Head of R&D) sold 5.1% of their position (4.62K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $71.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2025ACC: 0000950170-25-018993
Officer· President, Head of R&D
Since Apr 2023
-4.62K
Net shares
Net seller
$71.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.62K
Price / share
$15.50
Trade value
$71.60K
% of position
5.1%
2/10/2025
89.71K→85.09K
Total
Net shares
−4.62K
Net value
-$71.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2025 | S · Sale | −4.62K | $15.50 | $71.60K | 5.1% | 89.71K | 85.09K |
| Total | −4.62K | -$71.60K | ||||||
Derivative Transactions0
No derivative transactions reported